Advanced Macular Degeneration

Ocutrx Technologies has released its OcuLenz augmented reality/extended reality headset, which is designed to enhance visual clarity for people with advanced macular degeneration.

Dealing with new-onset macular exudation while treating geographic atrophy with the complement inhibitors currently undergoing investigation seems a risk not worth the reward.

New pharmacotherapies and novel approaches, such as gene therapy and cell therapy, are raising realistic hopes for patients with geographic atrophy, a condition that can lead to vision loss.

Age-related macular degeneration is a major cause of visual loss in the elderly. As many as 200 million individuals are affected globally.